Your browser doesn't support javascript.
loading
The implications of the PEPTIC trial for clinical practice.
Young, Paul J; Bagshaw, Sean M; Bellomo, Rinaldo; Nichol, Alistair D; Wright, Stephen E.
Affiliation
  • Young PJ; Intensive Care Unit, Wellington Hospital, Wellington, New Zealand. paul.young@ccdhb.org.nz.
  • Bagshaw SM; Department of Critical Care Medicine, University of Alberta Hospital, Alberta, Canada.
  • Bellomo R; Intensive Care Unit, Austin Hospital, Melbourne, VIC, Australia.
  • Nichol AD; Intensive Care Unit, St Vincent's Hospital, Dublin, Ireland.
  • Wright SE; Intensive Care Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Crit Care Resusc ; 22(1): 4-5, 2020 Mar.
Article in En | MEDLINE | ID: mdl-32102637
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptic Ulcer / Proton Pump Inhibitors / Histamine H2 Antagonists / Intensive Care Units Limits: Humans Language: En Journal: Crit Care Resusc Journal subject: TERAPIA INTENSIVA Year: 2020 Document type: Article Affiliation country: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptic Ulcer / Proton Pump Inhibitors / Histamine H2 Antagonists / Intensive Care Units Limits: Humans Language: En Journal: Crit Care Resusc Journal subject: TERAPIA INTENSIVA Year: 2020 Document type: Article Affiliation country: New Zealand